(Q33361842)
Statements
1 reference
A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumors (English)
1 reference
K Mross
1 reference
H Richly
1 reference
N Schleucher
1 reference
S Korfee
1 reference
M Tewes
1 reference
M E Scheulen
1 reference
S Seeber
1 reference
T Beinert
1 reference
M Schweigert
1 reference
U Sauer
1 reference
C Unger
1 reference
D Behringer
1 reference
E Brendel
1 reference
C G Haase
1 reference
D Voliotis
1 reference
D Strumberg
1 reference
1 August 2004
1 reference
1 reference
15
1 reference
1284-1294
1 reference
Identifiers
1 reference
1 reference